Identification of favorable subgroups for alternative anti-androgen therapy in castration-resistant prostate cancer

Although alternative anti-androgen therapy (switching to secondary anti-androgens) is no longer recommended in the clinical guidelines of prostate cancer in light of the new hormonal and cytotoxic agents available, this therapy has proven beneficial for some patients with castration-resistant prosta...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Mol Clin Oncol
Main Authors: Suzuki, Kotaro, Terakawa, Tomoaki, Shigemura, Katsumi, Furukawa, Junya, Harada, Kenichi, Hinata, Nobuyuki, Nakano, Yuzo, Fujisawa, Masato
Format: Artigo
Sprog:Inglês
Udgivet: D.A. Spandidos 2019
Fag:
Articles
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6787950/
https://ncbi.nlm.nih.gov/pubmed/31620284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2019.1915
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker